Poltreg S.A. among 5 Top Healthcare Startups Tackling Type 1 Diabetes. Portal startus-insights analyzed 72 healthcare startups tackling Type 1 Diabetes (T1D). Our company was scored among Top 5 developing medical solutions to watch out for.
More:
2020-09-01
September 2020
See other news
2025-01-20
PolTREG secures PLN 51.4M grant recommendation from Polish Agency for Enterprise Development for groundbreaking multiple sclerosis therapy
2025-01-09
PolTREG obtains Japanese patent for intrathecal PTG-007 therapy in multiple sclerosis
2024-11-14
PolTREG received a new patent from China for anti-gen specific Tregs cellular therapy
2024-09-26
PolTREG starts preclinical CAR-Treg development for neuroinflammatory autoimmune diseases
2024-09-16
China patent notification boosts PolTREG’s development of Treg cell therapy in multiple sclerosis
